DALLAS, Sept. 29, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring biopharmaceutical company Cell Therapeutics Inc. (Nasdaq:CTIC). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
Microstockprofit.com is the premiere destination for investment information, making your trading decisions easier than ever. Get the run down on how CTIC stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for small-cap stock CTIC at: http://www.microstockprofit.com/lp/CTIC
This newsletter has been helping traders make great investment decisions on CTIC; click here for a 25% discount offer.
In the CTIC, the analyst notes:
"Share of CTIC jumped as much as 8% on Wednesday after the Company said a second independent radiology assessment of data from a clinical trial of its antitumor treatment pixantrone confirmed the statistical robustness of the data."
"CTIC reported total operating expenses of $16.9 million for the second quarter ended June 30, 2011, down 15% from $20.0 million reported in the same period last year. The Company reported no revenues for the latest quarter."
To read the entire report visit: www.microstockprofit.com/lp/CTIC
See what investors are saying about CTIC at http://www.stockhideout.com
Get breaking news on CTIC at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.